BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2270030)

  • 1. [Drug therapy of hyperlipidemia].
    Kajiyama G; Horiuchi I
    Nihon Rinsho; 1990 Nov; 48(11):2620-8. PubMed ID: 2270030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid therapy. Prevention of arteriosclerotic cardiovascular diseases].
    Windler E
    Internist (Berl); 2001 Jan; 42(1):92-110. PubMed ID: 11271625
    [No Abstract]   [Full Text] [Related]  

  • 3. Lomitapide.
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):347-52. PubMed ID: 21846156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Update: clinical lipidology].
    Parhofer KG
    MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
    [No Abstract]   [Full Text] [Related]  

  • 6. A New Beginning for Triglyceride-Lowering Therapies.
    Pradhan AD
    Circulation; 2019 Jul; 140(3):167-169. PubMed ID: 30836784
    [No Abstract]   [Full Text] [Related]  

  • 7. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Update of lipid lowering therapy].
    Riesen WF; Mordasini RC
    Praxis (Bern 1994); 2008 Nov; 97(22):1179-84. PubMed ID: 18979436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel pharmacotherapies of familial hyperlipidemia.
    Drakopoulou M; Toutouzas K; Stefanadis C
    Pharmacol Ther; 2013 Sep; 139(3):301-12. PubMed ID: 23639874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Fixed-Dose Combination Treatments for Hyperlipidemia.
    Pappa E; Rizos CV; Filippatos TD; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):315-322. PubMed ID: 30909733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on fungus lipid-reducing capsule in regulating lipometabolic disorder].
    Lin QC; Ye Y; Fang SQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 May; 15(5):281-3. PubMed ID: 7640501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using omega-3 fatty acids in the practice of clinical lipidology.
    Brown WV; Bays H; Harris W; Miller M
    J Clin Lipidol; 2011; 5(6):424-33. PubMed ID: 22108145
    [No Abstract]   [Full Text] [Related]  

  • 14. [Simvastatin in the treatment of hypercholesterolemia].
    Cigala O; Pancallo MT; Della Valle M; Marasco A; Malarbi AL
    Clin Ter; 1991 Jun; 137(5):333-7. PubMed ID: 1832606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertriglyceridemia and coronary heart disease.
    Jones JD; Chambliss ML
    Arch Fam Med; 2000 Feb; 9(2):189-90. PubMed ID: 10693737
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of lipid-lowering treatment in France--the CEPHEUS study.
    Ferrières J; Gousse ET; Fabry C; Hermans MP;
    Arch Cardiovasc Dis; 2008 Sep; 101(9):557-63. PubMed ID: 19041840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of dyslipidemias].
    Fonda M; Cattin L; Guarnieri G
    Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
    Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
    Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
    [No Abstract]   [Full Text] [Related]  

  • 19. [New perspectives in the control of hypercholesterolemia with the use of HMG CoA reductase inhibitors].
    Ribeiro L; Kohn IJ
    Arq Bras Cardiol; 1990 Mar; 54(3):177-8. PubMed ID: 2288502
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipometabolic disorder--cholesterol and triglycerides].
    Luley C
    Clin Res Cardiol; 2006; 95 Suppl 6():VI17-22. PubMed ID: 17013580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.